WARREN, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy ...
Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...
HiveBio's partners on the new accelerator include Thomas Jefferson University, Drexel University, Robin Hood Ventures, ...
AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of ...
Patrick McGilligan's doorstopper of a biography addresses Woody Allen's professional achievements and also his personal ...
A team led by Harvard SEAS Postdoctoral Fellow Dr. John Zimmerman and including NTT Research Medical and Health Informatics Scientist Ryoma Ishii, Harvard SEAS Tarr Family Professor of Bioengineering ...
Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...
Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multiomic microbial identification services, today announced the acquisition of Anaerobe Systems, Inc.
According to leading experts, the following topics must now feature at the very top of the political agenda: the transition ...
Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today announced positive initial results from its previously ...
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results